Ncardia will exhibit and present at the WPC in Boston, MA, USA
Location: Boston, MA, USA
Date: June 17 - 20
Meet Ncardia at the 18th Annual World Preclinical Congress (WPC) in Boston! This Congress focuses on the latest trends and technologies impacting drug discovery and translational research, as well as offering a unique opportunity for chemists, pharmacologists, and screening experts in industry and academia as well as contract research organizations, such as Ncardia, to come together and exchange expertise.
Stefan Braam, CEO of Ncardia, will be making the following presentation:
- Rethinking the translational - the use of highly predictive hiPSC-derived models in pre-clinical drug development (more details)
Heather White and Mari Kennedy, Business Development & Sales, will also be in attendance and look forward to meeting you! Please drop by and visit us at Booth #222.
Ncardia poster presentations
High throughput phenotypic efficacy screening in a diseased model of cardiac hypertrophy using hiPSC-derived cardiomyocytes
Controlled, large scale manufacturing of hiPSC-derived cardiomyocytes in stirred-tank bioreactors enabling high throughput phenotypic screening